MiNK Therapeutics (NASDAQ:INKT) unveiled new translational data at the Keystone Symposia on Wednesday, providing the first direct evidence in humans that a specific immune cell deficiency may be a primary driver of the scarring that defines idiopathic pulmonary fibrosis (IPF).
Advanced Micro Devices (NASDAQ:AMD) shares fell as much as 8% in Wednesday trading after the chipmaker’s first-quarter revenue outlook failed to match the lofty expectations set by the AI-driven rally of late 2025.
GSK (NYSE:GSK) reported fourth-quarter results that cleared Wall Street estimates, as the British drugmaker successfully leveraged its high-growth specialty medicines to offset slowing demand for its flagship RSV vaccine, Arexvy.
Equinor (NYSE:EQNR) reported a robust finish to 2025 on Wednesday, as record-high oil and gas production helped the Norwegian energy giant weather a sharp decline in crude prices and significant impairments in its renewables business.
In times of uncertainty, we often look for something solid to hold onto. Lately, it seems the world’s investors have decided that “something solid” is, quite literally, gold.
The metal’s soaring price is more than just a market trend; it's a global barometer of anxiety.
When faith in currencies, governments, and traditional financial systems begins to waver, we see a familiar flight to the perceived safety of this timeless asset.
Well, pull out the party hats and dust off the stock tickers.
Lithium, the commodity that investors and analysts had all but left for dead in the great market purge of 2023-2024, is back.
The stock market has long treated Tesla (NASDAQ:TSLA) less as a traditional automaker and more as a futuristic technology cult, with its valuation soaring on the gravitational pull of its CEO, Elon Musk.
This persistent "Musk Premium" has burned countless short-sellers.
Bitcoin has vaporised more than US$800 billion in its latest crash and sucked US$1 trillion out of the broader crypto market.
With nearly US$2 trillion in market value and rising allocations from Wall Street firms, ETFs, pension funds, and insurers, Bitcoin is increasingly woven into traditional finance.
Japan’s bond market has been sliding all week, with the 10-year yield now near 2.37% and the 40-year pushing above 4.2%, both multi-decade highs.
U.S. President Donald Trump has escalated his confrontation with European leaders on the eve of the World Economic Forum in Davos, threatening to impose a 200% tariff on French wine and champagne.
If you think the Formula 1 season finale in Abu Dhabi is just about who gets to spray the rose water, you aren’t looking at the balance sheet.
As the sun sets over the Yas Marina Circuit this weekend, we aren’t just witnessing a sporting event; we are watching the closing bell of one of the most efficient capital-generating machines in modern sports.
TransDigm Group (NYSE:TDG) Tuesday reported fiscal first-quarter 2026 results, delivering double-digit growth driven by a resilient commercial aerospace aftermarket and intensifying defense spending.
Capri Holdings (NYSE:CPRI) today revealed third-quarter fiscal 2026 results, 2026, beating Wall Street expectations as the luxury group pivot's toward a leaner capital structure following the high-profile divestiture of Versace.
Pfizer (NYSE:PFE) reported fourth-quarter and full-year 2025 results on Tuesday, February 3, 2026, signaling a definitive shift away from its pandemic-era reliance.
Merck (NYSE:MRK) today reported fourth-quarter and full-year 2025 results that showcased a tale of two portfolios: a surging oncology and respiratory business set against a dramatic collapse in vaccine demand from China.
-640x360.jpg&w=1200&q=75)
-640x360.jpg&w=1200&q=75)
-640x400.jpg&w=1200&q=75)
